Myllykangas-Luosujärvi R, Aho K, Kautiainen H, Isomäki H
Rheumatism Foundation Hospital, Heinola, Finland.
Clin Exp Rheumatol. 1995 Mar-Apr;13(2):149-53.
To obtain information on the shortening of the life span and the causes of excess death in a population-based series of subjects with rheumatoid arthritis (RA).
The study included all 1666 subjects who had died in Finland in 1989 and were entitled under the nationwide sickness insurance scheme to receive specially reimbursed medication for RA. Demographic data on the Finnish population and sickness insurance statistics were used as the basis for computations.
The life span in subjects with RA was shortened by 15-20% from the date of onset of illness. The determinants of excess mortality could be studied in females. About 40% of the excess deaths were due to cardiovascular causes, 30% to infections, 15% to amyloidosis, and the remaining 15% to diverse causes.
This data provides an enlightened basis for understanding mortality associated with RA.
获取关于以人群为基础的类风湿关节炎(RA)患者系列中寿命缩短情况及额外死亡原因的信息。
该研究纳入了1989年在芬兰死亡且根据全国疾病保险计划有权获得RA特殊报销药物的所有1666名受试者。芬兰人口的人口统计学数据和疾病保险统计数据用作计算基础。
从疾病发病之日起,RA患者的寿命缩短了15% - 20%。可在女性中研究额外死亡率的决定因素。约40%的额外死亡归因于心血管原因,30%归因于感染,15%归因于淀粉样变性,其余15%归因于多种原因。
该数据为理解与RA相关的死亡率提供了有启发性的基础。